J. Goldman & CO LP Regeneron Pharmaceuticals, Inc. Put Options Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $11 Million - $12.9 Million	10,700 Added 535.0%	12,700 $13.4 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $1.77 Million - $2.14 Million	2,000 New	2,000 $2.1 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $10.8 Million - $13.2 Million	15,600 New	15,600 $12.8 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $5.92 Million - $7.19 Million	8,700 New	8,700 $7.15 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $4.59 Million - $5.79 Million	8,000 New	8,000 $5.51 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.